Tab. VIII.

Numero di sierotipi prevenibili mediante la vaccinazione anti-pneumococcica 13-valente e 15-valente nei bambini di 0-4 anni nel periodo 2011-2021 (Fonte dati: MaBI).

	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	Totale
1	11 (45,8)	4 (16,6%)	4 (16,6%)	3 (12,5%)	0	1 (4,2%)	0	1 (4,2%)	0	0	0	24
3	0	6 (28,6%)	1 (4,8%)	0	3 (14,3%)	0	3 (14,3%)	4 (19,1%)	1 (4,8%)	2 (9,5%)	1 (4,8%)	21
4	0	0	0	0	0	0	0	0	0	0	0	0
5	1 (100%)	0	0	0	0	0	0	0	0	0	0	1
6A	0	0	0	1 (50%)	0	0	0	1 (50%)	0	0	0	2
6B	1 (33,3%)	2 (66,6%)	0	0	0	0	0	0	0	0	0	3
7F	4 (40%)	3 (30%)	1 (10%)	0	0	0	0	0	2 (20%)	0	0	10
9V	2 (100%)	0	0	0	0	0	0	0	0	0	0	2
14	3 (16,6%)	8 (44,4%)	1 (5,5%)	1 (5,5%)	0	1 (5,5%)	3 (16,6%)	1 (5,5%)	0	0	0	18
18C	1 (50%)	1 (50%)	0	0	0	0	0	0	0	0	0	2
19A	9 (34,6%)	7 (26,9%)	0	4 (15,4%)	4 (15,4%)	1 (3,8%)	0	0	0	1 (3,8%)	0	26
19F	3 (21,4%)	1 (1,1%)	1 (7,1%)	0	3 (21,4%)	0	3 (21,4%)	3 (21,4%)	0	0	0	14
22f	4 (21,1%)	1 (5,3%)	3 (15,8%)	0	4 (21,1%)	2 (10,5%)	1 (5,3%)	2 (10,5%)	2 (10,5%)	0	0	19
23F	2 (0,4%)	1 (0,2%)	1 (0,2%)	0	1 (0,2%)	0	0	0	0	0	0	5
33f	1 (8,3%)	2 (16,6%)	1 (8,3%)	2 (16,6%)	1 (8,3%)	1 (8,3%)	1 (8,3%)	1 (8,3%)	2 (16,6%)	0	0	12
Totale	42 (26,4%)	36 (22,6%)	13 (8,2%)	11 (6,9%)	16 (10,1%)	6 (3,8%)	11 (6,9%)	13 (8,2%)	7 (4,40%)	3 (1,88%)	1 (0,6%)	159